JNL/Mellon Healthcare Sector I (FVUSA04AXZ)
41.09
+0.19
(+0.46%)
USD |
Mar 30 2023
Key Stats
| Expense Ratio | Total Assets Under Management | Dividend Yield | Turnover Ratio |
|---|---|---|---|
| 0.28% | 3.413B | 0.00% | 3.00% |
| 1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized All Time Total Returns (Daily) | Max Drawdown (All) |
| -334.28M | -7.72% | Upgrade | Upgrade |
Basic Info
| Investment Strategy | |
| The investment seeks to track the performance of the Morningstar ® US Healthcare Sector Index SM to provide total return through capital appreciation and dividend income. The fund invests under normal circumstances at least 80% of its assets (net assets plus the amount of any borrowings made for investment purposes) in the securities in the index in proportion to their market capitalization weighting in the index. The index measures the performance of companies of biotechnology, pharmaceuticals, research services, home healthcare, hospitals, long-term care facilities, and medical equipment and supplies. The fund is non-diversified. |
| General | |
| Security Type | Mutual Fund |
| Oldest Share Symbol | FVUSA000Y4 |
| Equity Style | Large Cap/Blend |
| Fixed Income Style | -- |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Category Name | Health |
| Category Index | S&P 1500 Health Care TR |
| Global Category Name | Healthcare Sector Equity |
| YCharts Categorization | Healthcare Equity |
| YCharts Benchmark | S&P 1500 Health Care (Sector) Total Return (^SP15HCSTR) |
| Prospectus Objective | Specialty - Health |
| Fund Owner Firm Name | Jackson National |
| Prospectus Benchmark Index | |
| Morningstar US Health TR USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^MSWNTR | 100.0% |
| Manager Tenure | |
| David France | 2.34 yrs |
| Marlene Walker-Smith | 2.34 yrs |
| Michael Stoll | 2.34 yrs |
| Todd Frysinger | 2.34 yrs |
| Vlasta Sheremeta | 2.34 yrs |
Net Fund Flows Versus Category
1 Month
% Rank:
--
--
Category Low
--
Category High
1 Year
% Rank:
89
-334.28M
-2.719B
Category Low
6.230B
Category High
3 Months
% Rank:
--
--
Category Low
--
Category High
3 Years
% Rank:
--
--
Category Low
--
Category High
6 Months
% Rank:
--
--
Category Low
--
Category High
5 Years
% Rank:
--
--
Category Low
--
Category High
YTD
% Rank:
--
--
Category Low
--
Category High
10 Years
% Rank:
--
--
Category Low
--
Category High
As of February 28, 2023
Risk
Performance Versus Category
As of March 29, 2023. Returns for periods of 1 year and above are annualized.
Annual Total Returns Versus Peers
As of March 29, 2023.
Asset Allocation
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| UnitedHealth Group Inc | 8.69% | 469.96 | 0.72% |
| Johnson & Johnson | 8.10% | 153.44 | 0.08% |
| Eli Lilly and Co | 5.06% | 340.69 | 1.44% |
| Pfizer Inc | 5.05% | 40.37 | 0.30% |
| AbbVie Inc | 5.01% | 157.90 | -0.06% |
|
Merck & Co Inc
|
4.97% | -- | -- |
| Thermo Fisher Scientific Inc | 3.80% | 563.08 | 1.43% |
| Abbott Laboratories | 3.36% | 99.08 | 0.47% |
| Danaher Corp | 3.06% | 249.77 | 0.93% |
| Bristol-Myers Squibb Co | 2.69% | 68.21 | 0.04% |
Basic Info
| Investment Strategy | |
| The investment seeks to track the performance of the Morningstar ® US Healthcare Sector Index SM to provide total return through capital appreciation and dividend income. The fund invests under normal circumstances at least 80% of its assets (net assets plus the amount of any borrowings made for investment purposes) in the securities in the index in proportion to their market capitalization weighting in the index. The index measures the performance of companies of biotechnology, pharmaceuticals, research services, home healthcare, hospitals, long-term care facilities, and medical equipment and supplies. The fund is non-diversified. |
| General | |
| Security Type | Mutual Fund |
| Oldest Share Symbol | FVUSA000Y4 |
| Equity Style | Large Cap/Blend |
| Fixed Income Style | -- |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Category Name | Health |
| Category Index | S&P 1500 Health Care TR |
| Global Category Name | Healthcare Sector Equity |
| YCharts Categorization | Healthcare Equity |
| YCharts Benchmark | S&P 1500 Health Care (Sector) Total Return (^SP15HCSTR) |
| Prospectus Objective | Specialty - Health |
| Fund Owner Firm Name | Jackson National |
| Prospectus Benchmark Index | |
| Morningstar US Health TR USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^MSWNTR | 100.0% |
| Manager Tenure | |
| David France | 2.34 yrs |
| Marlene Walker-Smith | 2.34 yrs |
| Michael Stoll | 2.34 yrs |
| Todd Frysinger | 2.34 yrs |
| Vlasta Sheremeta | 2.34 yrs |
Fundamentals
| General | |
| Distribution Yield | Upgrade |
| Dividend Yield TTM (3-29-23) | 0.00% |
| 30-Day SEC Yield | -- |
| 7-Day SEC Yield | -- |
| Number of Holdings | Upgrade |
| Stock | |
| Weighted Average PE Ratio | 22.70 |
| Weighted Average Price to Sales Ratio | Upgrade |
| Weighted Average Price to Book Ratio | Upgrade |
| Weighted Median ROE | Upgrade |
| Weighted Median ROA | Upgrade |
| Forecasted Dividend Yield | Upgrade |
| Forecasted PE Ratio | Upgrade |
| Forecasted Price to Sales Ratio | Upgrade |
| Forecasted Price to Book Ratio | Upgrade |
As of December 31, 2022
Fund Details
| Key Dates | |
| Inception Date | 3/5/2004 |
| Last Annual Report Date | 12/31/2022 |
| Last Prospectus Date | 4/25/2022 |
| Share Classes | |
| FVUSA000Y4 | No Load |
| Attributes | |
| Index Fund |
|
| Inverse Fund | No |
| Leveraged Fund | No |
| Fund of Funds | No |
| Currency Hedged Fund | No |
| Synthetic Replication Fund | No |
| Has Dividend Investment Plan | No |
| Socially Responsible Fund | No |